Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
about
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progressionAEG-1/MTDH/LYRIC in liver cancerCirculating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinomaInvestigation of key microRNAs associated with hepatocellular carcinoma using small RNA-seq data.Anti-proliferative effect of extremely low frequency electromagnetic field on preneoplastic lesions formation in the rat liver.Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumoursNon-alcoholic fatty liver disease: An expanded reviewChemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular CarcinomaOverexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinomaHigh expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients.An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers.Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells.Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinomaGenetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferationAldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaAlterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy.Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United StatesOverexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.An overview of biomarkers for the diagnosis of hepatocellular carcinoma.S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.High dietary inorganic phosphate enhances cap-dependent protein translation, cell-cycle progression, and angiogenesis in the livers of young mice.Role of methionine adenosyltransferase genes in hepatocarcinogenesisRecent advances in the natural history of hepatocellular carcinoma.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma.
P2860
Q24647547-BD5324A0-D6A7-41A8-B60C-66E40D45C46DQ26822570-67D29BDA-7FBD-42AA-9BBA-B4BA670133C5Q27485911-963DF067-8268-479A-AE2B-3BB615A7D82FQ30776344-7682419F-26AF-4CE5-861D-A29B253E9165Q33563339-4389B5FB-5D50-4EBD-83F1-0517446660FEQ33590076-EACA431A-B2BC-49FC-9B2A-821F27620249Q33601430-7A9FB328-6233-473E-B52D-8B970C956F7EQ33688583-0C08C6E1-92C5-4A8F-97A0-F7E040CA5963Q33711578-F5C58172-6D4A-48EF-932D-755F158F22A2Q33789868-89515261-73A9-49E8-A5E5-FCEBFB41A8A7Q33809381-AEAD91FD-38F0-4EF1-929E-E47E24C8981FQ33898809-0B5424F0-B64B-4983-92E1-12B17E5D5B12Q33911829-A5749610-23DC-4646-88DE-92B235C14720Q34186021-20661F03-2B00-4800-B3A6-6D80640F8E1EQ34390176-2313E244-903A-4AFF-B291-E4FB0E46D5B5Q34500720-DCFF4ACD-F162-40DE-86F0-8A73B94FCFD0Q34627182-7444A716-6D3C-477A-B9E6-C2A7E24F2BF3Q34669811-2DA985AD-63E1-413E-B625-E4C9B0C23FBBQ34744836-F4EE41D5-7805-4966-BB9F-7AAF4F257BFFQ35084843-6924A6BB-A0A6-40D2-A41C-AF1A9DFA1BCBQ35233688-97EE5DFF-3AB4-4A28-89DE-5D16D7C42B40Q35274662-D0B1EB99-62DD-4D4B-8CF2-8B99096EF1E1Q35658932-655D9718-D256-4AE3-96DB-91B480720E54Q35708594-5EE5D7D2-13D0-4BB7-83A7-9D524D081178Q35927161-14598010-8C9E-4723-8337-02C282BE4860Q36014285-578AD2C5-367B-4CB2-A0D2-1593FB4498BBQ36070832-C9B056A7-7647-4409-8EF3-54CC2B1A0712Q36092123-DD9236C2-C7DA-4275-81DF-A043CBCB7E6CQ36102829-F5E22A24-F920-42F1-B47C-6D3736984550Q36202481-EA02D532-9951-4AE6-B8A7-78D0DD6C3E03Q36230751-EC1E10A2-C48E-4367-987F-8BD5BB46CA4EQ36248210-39660B41-3B13-4ADB-B360-9F98AD3EF4D3Q36395289-0CD143DB-DC43-4701-9F3F-EE361B6A95DBQ36694479-567F535C-F7F2-4148-ACAC-BBA34726B7C7Q36698843-695AE83D-9D73-476B-9744-9061EEEDD4C5Q36956086-8BDF6BBF-5040-4BE8-9BFC-5D6D3691DA7DQ37132635-D72E9635-7AC5-40FF-96D4-2D6AF9ADA416Q37178623-C4D69D29-B265-4EA1-B76F-BE659821A8E7Q37463744-46D6D417-C5EE-4002-A3F8-E22B5D67CB99Q37581647-A31B1975-54BC-4525-86DC-9EB2ABE296AA
P2860
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@ast
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@en
type
label
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@ast
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@en
prefLabel
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@ast
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@en
P2093
P1476
Prognostic molecular markers in hepatocellular carcinoma: a systematic review.
@en
P2093
Ashley R Dennison
Christopher D Mann
Christopher P Neal
David P Berry
Giuseppe Garcea
Margaret M Manson
P304
P356
10.1016/J.EJCA.2007.01.004
P577
2007-02-08T00:00:00Z